Health
Sinopharm vaccine for COVID-19 elicits immunity to South Africa variant, but with minor effect – Explica
BEIJING, Feb 3 (.) – Two COVID-19 vaccines from Chinese companies, including Sinopharm, elicited immunity against a highly communicable variant of the coronavirus…
BEIJING, Feb 3 (.) – Two COVID-19 vaccines from Chinese companies, including Sinopharm, elicited immunity against a highly communicable variant of the coronavirus first found in South Africa, but its effect appeared to be weaker, a study showed laboratory with small samples.
Variants of the virus have raised concerns that they may weaken the effects of vaccines and treatments developed before their emergence.
Twelve serum samples taken from recipients of two vaccines developed by a Sinopharm subsidiary…
-
Noosa News12 hours agoConsolidated Pastoral Company buys Beetaloo aggregation in historic deal worth more than $300m
-
General20 hours agoWotjobaluk Nations Festival marks landmark native title recognition
-
General14 hours agoAustralian luger Alex Ferlazzo makes stunning recovery during run after falling off his sled
-
Business24 hours agoWhat Warren Buffett’s latest portfolio moves say about the market